PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Profacgen Announces New Offering of ADME Tox Prediction .pdf


Original filename: Profacgen Announces New Offering of ADME Tox Prediction.pdf
Author: Windows 用户

This PDF 1.5 document has been generated by Microsoft® Word 2013, and has been sent on pdf-archive.com on 22/03/2018 at 03:49, from IP address 182.148.x.x. The current document download page has been viewed 110 times.
File size: 108 KB (1 page).
Privacy: public file




Download original PDF file









Document preview


Profacgen Announces New Offering of ADME/Tox Prediction for Drug Development
Profacgen announced its new offering of ADME/Tox Prediction services for drug development.
Taking advantage of the most state-of-the-art ADME and Tox property prediction computational
methods and software, Profacgen helps customers to quickly and accurately predict over 100
properties including solubility, logP and pKa, etc.
The characterization of Absorption, Distribution, Metabolism, and Excretion (also known as
ADME) and Toxicity are essential steps in drug development. ADME describes the disposition
of a pharmaceutical compound within an organism, and has been applied in drug discovery to
investigate the drug levels and kinetics of drug exposure to the tissues and hence influences
the performance and pharmacological activity of the compound as a drug.
“We hold a group of scientists with in-depth understanding of structure-property relationships.
We strive to provide computational predictions of ADME, toxicological and physicochemical
properties, as well as the analysis and interpretation of the predicted data. And our ADME/Tox
prediction can be customized based on the specific requirements from our customers.”
Commented Crystal, a representative from Profacgen.
More information about this newly launched ADME/Tox Prediction service from Profacgen can
be found at https://www.profacgen.com/adme-tox-prediction.htm.
About Profacgen
Profacgen provides process development and cGMP manufacturing services for biological
active ingredients. We have ready access to state-of-the-art biopharmaceutical product
development and manufacturing facilities and our staff scientists have demonstrable expertise
in all aspects of biopharmaceutical manufacturing, from facility design and operation to the
ability to provide best advice relating to product development. We also save our clients a great
deal of time with bioprocess scale-up services. Our fermentation laboratories are equipped with
state-of-the-art fermentors and bioreactors that enable us to express protein in large scale. Our
customers can choose to enter into the protein purification pipeline at any stage depending on
their needs.


Document preview Profacgen Announces New Offering of ADME Tox Prediction.pdf - page 1/1

Related documents


profacgen announces new offering of adme tox prediction
profacgen launched one stop fusion protein production service
mitochondrial proteins
pegylation technology and biopharmaceuticals
untitled pdf document 1
untitled pdf document 1


Related keywords